Lactobacillus brevis strains from fermented aloe vera survive gastroduodenal environment and suppress common food borne enteropathogens

PLoS One. 2014 Mar 5;9(3):e90866. doi: 10.1371/journal.pone.0090866. eCollection 2014.

Abstract

Five novel Lactobacillus brevis strains were isolated from naturally fermented Aloe vera leaf flesh. Each strain was identified by Random Amplified Polymorphic DNA (RAPD) analysis and 16S rRNA sequence comparison. These strains were highly tolerant to acid, surviving in pH2.5 for up to 4 hours, and resistant to 5% bile salts at 37°C for 18 hours. Due to its tolerance to acid and bile salts, one strain passed through the gastric barrier and colonised the intestine after oral administration. All five strains inhibited the growth of many harmful enteropathogens without restraining most of normal commensals in the gut and hence named POAL (Probiotics Originating from Aloe Leaf) strains. Additionally, each strain exhibited discriminative resistance to a wide range of antibiotics. The L. brevis POAL strains, moreover, expressed high levels of the glutamate decarboxylase (GAD) gene which produces a beneficial neurotransmitter, γ-aminobutyric acid (GABA). These characteristics in all suggest that the novel L. brevis strains should be considered as potential food additives and resources for pharmaceutical research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aloe / microbiology*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Base Sequence
  • Bile Acids and Salts / pharmacology
  • Duodenum / microbiology*
  • Fermentation* / drug effects
  • Food Microbiology*
  • Glutamate Decarboxylase / genetics
  • Glutamate Decarboxylase / metabolism
  • Hydrogen-Ion Concentration
  • Levilactobacillus brevis / drug effects
  • Levilactobacillus brevis / isolation & purification*
  • Mice
  • Microbial Sensitivity Tests
  • Microbial Viability* / drug effects
  • Molecular Sequence Data
  • Phylogeny
  • Plant Leaves / microbiology
  • Probiotics / pharmacology
  • RNA, Ribosomal, 16S / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stomach / microbiology*

Substances

  • Anti-Bacterial Agents
  • Bile Acids and Salts
  • RNA, Ribosomal, 16S
  • Glutamate Decarboxylase

Associated data

  • GENBANK/JX185493
  • GENBANK/JX185494
  • GENBANK/JX185495
  • GENBANK/JX185496
  • GENBANK/JX185497

Grants and funding

This study was supported by KBNP Inc., a manufacturing company specialising in animal health products for providing funding in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.